D.C. Denies Prostate Cancer Vaccine, Provenge: Dendreon (WA) Not FDA To Blame

Main Category: Prostate / Prostate Cancer
Also Included In: Immune System / Vaccines
Article Date: 31 Jul 2007 - 0:00 PDT

Current ratings for:
'D.C. Denies Prostate Cancer Vaccine, Provenge: Dendreon (WA) Not FDA To Blame'

Patient / Public:4 stars

3.78 (9 votes)

Healthcare Prof:1 star

1 (1 votes)


Many in the prostate cancer community are still outraged over the FDA's decision to deny approval for the immunotherapy drug Provenge. Some have even gone as far as to make threats against Howard I. Scher of Memorial Sloan-Kettering Cancer Center (NY) and Maha Hussain of University of Michigan, two physicians who influenced this decision.

However, Dr. Charles "Snuffy" Myers, leading PC oncologist and VA prostate cancer survivor, remains staunch in his objections to the trials Dendreon presented to the FDA despite the benefits the drug might bring to his patients and himself. Myers has written extensively on this subject in his Prostate Forum newsletters 10 #01 and 10 #02, available at http://www.prostateforum.com.

"Dendreon made major and obvious mistakes in developing Provenge. The FDA is not some sort of bad guy -- at least in this case and yet Dendreon's stock continues to rise," Myers' says. "The primary end point of a clinical trial seeking FDA approval should be either survival or improved quality of life, but Dendreon still chose to muddy the waters by changing endpoints midway through the clinical trial, forcing the FDA's hand with their poor design."

"This is actually the second time that we've had a useful drug fail in development. The other was Atrasentan (a.k.a. Xinlay)," Myers adds. "Again, it failed not because of the FDA but because of drug company incompetence. While the FDA is far from perfect, people need to understand who to blame in this case."

"I can understand the anger," Myers says, "but is it really unreasonable to ask for proof that a drug is safe and either improves survival or quality of life? I think that Provenge is an active agent with a definite, but limited, benefit, so I feel a personal loss now that it is not going to be available. But killing the messenger doesn't change the message; it just obscures the real problem -- and solving problems is what modern medicine should really be about."

Former director of the UVA Cancer Center, Dr. Charles "Snuffy" Myers is the author of the acclaimed Beating Prostate Cancer: Hormonal Therapy & Diet and runs the American Institute for Diseases of the Prostate to treat patients with the same tools that saved his own life. For more information or to read Dr. Myers' opinions on Provenge visit http://www.prostateforum.com.

Prostate Forum
http://www.prostateforum.com

View drug information on Provenge.


Article adapted by Medical News Today from original press release.
Visit our prostate / prostate cancer section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Prostate Forum. "D.C. Denies Prostate Cancer Vaccine, Provenge: Dendreon (WA) Not FDA To Blame." Medical News Today. MediLexicon, Intl., 31 Jul. 2007. Web.
26 May. 2012. <http://www.medicalnewstoday.com/releases/78299.php>

APA
Prostate Forum. (2007, July 31). "D.C. Denies Prostate Cancer Vaccine, Provenge: Dendreon (WA) Not FDA To Blame." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/78299.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'D.C. Denies Prostate Cancer Vaccine, Provenge: Dendreon (WA) Not FDA To Blame'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Prostate / Prostate Cancer

What Is Prostate Cancer?

Prostate cancer is a disease which only affects men. Cancer begins to grow in the prostate - a gland in the male reproductive system. The word "prostate" comes from Medieval Latin prostate and Medieval French prostate. Read more...

Most Popular Articles



Follow Our Prostate News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Prostate / Prostate Cancer Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »